GL1X · GenesisL1 explorer

UniProt P10827

Isoform Alpha-1 of Thyroid hormone receptor alpha (P10827)

Isoform Alpha-1 of Thyroid hormone receptor alpha (UniProt P10827): 9 experimental structures and 1 predicted model on GenesisL1, 3 ligands bound, 14 pockets. Binding sites, druggability and experiment against prediction…

UniProt
P10827
Protein
Isoform Alpha-1 of Thyroid hormone receptor alpha
Experimental structures
9
Predicted models
1
Ligands
3
Pockets
14 · 3 records with a druggable one

Structures

10 records of P10827 in the MolNFT archive: 9 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1NAVThyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1x-ray diffractionA——
1NAVThyroid receptor alpha in complex with an agonist selective for thyroid receptor BETA1x-ray diffractionA——
4LNWCrystal structure of TR-alpha bound to T3 in a second sitex-ray diffractionA——
4LNWCrystal structure of tr-alpha bound to T3 in a second sitex-ray diffractionA——
4LNXCrystal structure of TR-alpha bound to T4 in a second sitex-ray diffractionA——
4LNXCrystal structure of tr-alpha bound to T4 in a second sitex-ray diffractionA——
7QDTCrystal structure of a mutant (P393GX) Thyroid Receptor Alpha ligand binding domain designed to…x-ray diffractionAT33 (best 0.79)
7QDTCrystal structure of a mutant (P393GX) thyroid receptor alpha ligand binding domain designed to…x-ray diffractionAT3—
8RQOHuman thyroid hormone receptor alpha ligand binding domain in complex with beta-selective agonist…x-ray diffractionAA1H2J, SO45 (best 0.82)
P10827AlphaFold monomer V2.0 prediction for thyroid hormone receptor alpha (P10827)predictedA—6 (best 0.82)

Ligands

  • T3 · 3,5,3'triiodothyronine · in 2 records
  • A1H2J · 6-azanyl-2-[3,5-bis(chloranyl)-4-[(6-oxidanylidene-5-propan-2-yl-1~{H}-pyridazin-3-yl)oxy]phenyl]-1,2,4-triazine-3,5-dione · in 1 record
  • SO4 · Sulfate ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.